AEye Other Operating Expenses vs Research Development Analysis

LIDRW Stock

USD 0.01 0 15.00%

AEye financial indicator trend analysis is way more than just evaluating AEye Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AEye Inc is a good investment. Please check the relationship between AEye Other Operating Expenses and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in AEye Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Other Operating Expenses vs Research Development

Other Operating Expenses vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AEye Inc Other Operating Expenses account and Research Development. At this time, the significance of the direction appears to have almost identical trend.

The correlation between AEye's Other Operating Expenses and Research Development is 0.91. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Research Development in the same time period over historical financial statements of AEye Inc, assuming nothing else is changed. The correlation between historical values of AEye's Other Operating Expenses and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of AEye Inc are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Other Operating Expenses i.e., AEye's Other Operating Expenses and Research Development go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AEye Inc. It is also known as AEye overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Research Development

Most indicators from AEye's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AEye Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in AEye Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Sales General And Administrative To Revenue is likely to climb to 18.10 in 2024, whereas Selling General Administrative is likely to drop slightly above 22.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	62.6M	93.7M	73.9M	56.7M
Cost Of Revenue	3.6M	8.7M	15.3M	16.1M

Total Operating Expenses Cost Of Revenue

AEye fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Net Receivables	Common Stock Total Equity	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Short Term Debt
Total Assets		0.96	0.55	0.97	-0.68	0.82	0.77	0.87	0.63	0.99	0.86	0.66	0.57	0.88	-0.31	-0.69	0.79	0.61	-0.39	0.77	0.99	0.86	0.34	0.45	-0.04	0.4
Other Current Liab	0.96		0.7	0.86	-0.83	0.65	0.9	0.95	0.8	0.92	0.84	0.81	0.71	0.95	-0.08	-0.78	0.93	0.73	-0.53	0.9	0.92	0.92	0.56	0.33	-0.23	0.51
Total Current Liabilities	0.55	0.7		0.34	-0.59	0.25	0.82	0.57	0.96	0.51	0.72	0.98	0.46	0.84	0.58	-0.93	0.85	0.44	-0.79	0.82	0.5	0.47	0.37	0.2	-0.65	0.93
Total Stockholder Equity	0.97	0.86	0.34		-0.56	0.88	0.61	0.79	0.41	0.98	0.77	0.45	0.46	0.74	-0.53	-0.52	0.63	0.51	-0.21	0.62	0.98	0.8	0.21	0.48	0.14	0.21
Retained Earnings	-0.68	-0.83	-0.59	-0.56		-0.24	-0.92	-0.91	-0.75	-0.63	-0.41	-0.75	-0.72	-0.82	-0.03	0.7	-0.9	-0.73	0.64	-0.92	-0.65	-0.91	-0.77	0.23	0.47	-0.28
Net Receivables	0.82	0.65	0.25	0.88	-0.24		0.42	0.54	0.23	0.87	0.71	0.31	0.03	0.61	-0.58	-0.46	0.41	0.08	-0.23	0.42	0.86	0.53	-0.21	0.52	0.08	0.29
Common Stock Total Equity	0.77	0.9	0.82	0.61	-0.92	0.42		0.88	0.9	0.73	0.63	0.93	0.6	0.96	0.16	-0.91	0.98	0.6	-0.81	1.0	0.74	0.85	0.58	-0.04	-0.61	0.61
Other Stockholder Equity	0.87	0.95	0.57	0.79	-0.91	0.54	0.88		0.73	0.83	0.66	0.72	0.73	0.89	-0.14	-0.66	0.91	0.75	-0.53	0.88	0.83	0.99	0.69	0.12	-0.27	0.34
Total Liab	0.63	0.8	0.96	0.41	-0.75	0.23	0.9	0.73		0.57	0.72	0.99	0.65	0.89	0.52	-0.89	0.94	0.63	-0.76	0.9	0.56	0.65	0.59	0.15	-0.6	0.82
Total Current Assets	0.99	0.92	0.51	0.98	-0.63	0.87	0.73	0.83	0.57		0.84	0.61	0.49	0.85	-0.37	-0.67	0.74	0.53	-0.37	0.73	1.0	0.82	0.25	0.46	-0.02	0.39
Common Stock	0.86	0.84	0.72	0.77	-0.41	0.71	0.63	0.66	0.72	0.84		0.72	0.51	0.8	0.05	-0.69	0.72	0.53	-0.35	0.64	0.82	0.59	0.23	0.74	-0.04	0.7
Short Long Term Debt Total	0.66	0.81	0.98	0.45	-0.75	0.31	0.93	0.72	0.99	0.61	0.72		0.55	0.92	0.46	-0.96	0.94	0.54	-0.82	0.93	0.61	0.64	0.49	0.12	-0.65	0.84
Property Plant And Equipment Net	0.57	0.71	0.46	0.46	-0.72	0.03	0.6	0.73	0.65	0.49	0.51	0.55		0.56	0.19	-0.36	0.69	1.0	-0.11	0.6	0.48	0.71	0.91	0.23	0.05	0.18
Current Deferred Revenue	0.88	0.95	0.84	0.74	-0.82	0.61	0.96	0.89	0.89	0.85	0.8	0.92	0.56		0.08	-0.92	0.97	0.57	-0.75	0.96	0.85	0.84	0.46	0.2	-0.49	0.68
Net Debt	-0.31	-0.08	0.58	-0.53	-0.03	-0.58	0.16	-0.14	0.52	-0.37	0.05	0.46	0.19	0.08		-0.3	0.22	0.13	-0.37	0.16	-0.39	-0.24	0.27	-0.08	-0.52	0.61
Accounts Payable	-0.69	-0.78	-0.93	-0.52	0.7	-0.46	-0.91	-0.66	-0.89	-0.67	-0.69	-0.96	-0.36	-0.92	-0.3		-0.88	-0.36	0.87	-0.91	-0.68	-0.6	-0.27	-0.07	0.69	-0.82
Cash	0.79	0.93	0.85	0.63	-0.9	0.41	0.98	0.91	0.94	0.74	0.72	0.94	0.69	0.97	0.22	-0.88		0.69	-0.75	0.98	0.74	0.86	0.65	0.09	-0.53	0.65
Non Current Assets Total	0.61	0.73	0.44	0.51	-0.73	0.08	0.6	0.75	0.63	0.53	0.53	0.54	1.0	0.57	0.13	-0.36	0.69		-0.09	0.6	0.53	0.74	0.89	0.25	0.09	0.16
Non Currrent Assets Other	-0.39	-0.53	-0.79	-0.21	0.64	-0.23	-0.81	-0.53	-0.76	-0.37	-0.35	-0.82	-0.11	-0.75	-0.37	0.87	-0.75	-0.09		-0.81	-0.38	-0.47	-0.22	0.31	0.94	-0.72
Other Assets	0.77	0.9	0.82	0.62	-0.92	0.42	1.0	0.88	0.9	0.73	0.64	0.93	0.6	0.96	0.16	-0.91	0.98	0.6	-0.81		0.74	0.85	0.58	-0.04	-0.61	0.61
Cash And Short Term Investments	0.99	0.92	0.5	0.98	-0.65	0.86	0.74	0.83	0.56	1.0	0.82	0.61	0.48	0.85	-0.39	-0.68	0.74	0.53	-0.38	0.74		0.83	0.25	0.42	-0.04	0.36
Common Stock Shares Outstanding	0.86	0.92	0.47	0.8	-0.91	0.53	0.85	0.99	0.65	0.82	0.59	0.64	0.71	0.84	-0.24	-0.6	0.86	0.74	-0.47	0.85	0.83		0.68	0.06	-0.22	0.22
Non Current Liabilities Total	0.34	0.56	0.37	0.21	-0.77	-0.21	0.58	0.69	0.59	0.25	0.23	0.49	0.91	0.46	0.27	-0.27	0.65	0.89	-0.22	0.58	0.25	0.68		-0.13	-0.17	0.07
Inventory	0.45	0.33	0.2	0.48	0.23	0.52	-0.04	0.12	0.15	0.46	0.74	0.12	0.23	0.2	-0.08	-0.07	0.09	0.25	0.31	-0.04	0.42	0.06	-0.13		0.53	0.33
Other Current Assets	-0.04	-0.23	-0.65	0.14	0.47	0.08	-0.61	-0.27	-0.6	-0.02	-0.04	-0.65	0.05	-0.49	-0.52	0.69	-0.53	0.09	0.94	-0.61	-0.04	-0.22	-0.17	0.53		-0.61
Short Term Debt	0.4	0.51	0.93	0.21	-0.28	0.29	0.61	0.34	0.82	0.39	0.7	0.84	0.18	0.68	0.61	-0.82	0.65	0.16	-0.72	0.61	0.36	0.22	0.07	0.33	-0.61

Click cells to compare fundamentals

AEye Account Relationship Matchups

AEye fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	98.0	2.5M	6.6M	6.7M	4.1M	3.7M
Total Current Liabilities	2.4K	37.6M	13.6M	22.6M	10.0M	15.4M
Total Stockholder Equity	22.6K	(18.2M)	168.8M	94.0M	29.0M	50.2M
Retained Earnings	(2.4K)	(86.8M)	(151.8M)	(250.5M)	(337.6M)	(320.8M)
Net Receivables	143K	156K	4.2M	617K	131K	124.5K
Other Stockholder Equity	25.0K	68.5M	320.9M	345.7M	366.6M	202.0M
Total Liab	2.4K	44.1M	17.4M	39.4M	25.3M	23.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for AEye Stock Analysis

When running AEye's price analysis, check to measure AEye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AEye is operating at the current time. Most of AEye's value examination focuses on studying past and present price action to predict the probability of AEye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AEye's price. Additionally, you may evaluate how the addition of AEye to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AEye Other Operating Expenses vs Research Development Analysis

Other Operating Expenses vs Research Development

Other Operating Expenses vs Research Development Correlation Analysis

Correlation Coefficient

Other Operating Expenses

Research Development

AEye fundamental ratios Correlations

AEye Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AEye fundamental ratios Accounts

Also Currently Popular

Additional Tools for AEye Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Assets	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 1.0	Total Current Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Common Stock Shares Outstanding	+ 0.99	Other Stockholder Equity

Accounts Payable	- 0.96	Short Long Term Debt Total
Accounts Payable	- 0.93	Total Current Liabilities
Accounts Payable	- 0.92	Current Deferred Revenue
Other Assets	- 0.92	Retained Earnings
Common Stock Total Equity	- 0.92	Retained Earnings
Other Assets	- 0.91	Accounts Payable